DacryoCATH— 510(k) K142914

Name: FDA 510(k) clearance K142914
Creator: U.S. Food and Drug Administration
Published: 2015-01-12

Substantially Equivalent

Armadillo Biomedical, LLC

FDA 510(k) clearance K142914 for DacryoCATH, Substantially Equivalent on 2015-01-12. Applicant: Armadillo Biomedical, LLC. Device class: Unclassified.

Clearance details

Applicant: Armadillo Biomedical, LLC
Product code: Code OKS
Device class: Unclassified
Advisory panel: Unknown
Date received: 2014-10-07
Decision date: 2015-01-12
Decision: Substantially Equivalent
Clearance type: Special
Location: Encino, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code OKS

view all

K201892 — Ritleng®+ and Ritleng®+ PVP2021-03-11
K201606 — LacriJet®2020-12-18
K170247 — Lacriflow CL2017-04-18
K161373 — Nunchaku2016-11-03
K160710 — Oasis Lacrimal Intubation Set2016-05-13

More clearances from Armadillo Biomedical, LLC

view all

K113508 — DACRYOCATH2012-08-31

Data sourced from openFDA. This site is unofficial and independent of the FDA.